Cerebrovascular blockage is the same as cerebral infarction. After cerebrovascular blockage, patients will have a series of neurological deficits, and the infarct foci will be found after head CT or MRI, which is actually cerebral infarction. The treatment of cerebral infarction in the acute stage includes thrombolytic therapy, which can be given to the patient with intravenous application of alteplase or urokinase for thrombolytic therapy. If the patient’s thrombolysis is successful, the symptoms of neurological deficit can be significantly improved or reduced. If the patient is not eligible for thrombolysis, active antiplatelet aggregation, anticoagulation, and fiber-lowering should be given to the patient, together with the medication of activating blood circulation and removing blood stasis, and scavenging oxygen free radicals. After active treatment, dizziness, headache, numbness, weakness of limbs, clumsiness of speech and other symptoms of neurological deficits can be reduced to some extent. If there are sequelae, the patient can also be given subsequent rehabilitation treatment.